SPLASH BEVERAGE GROUP, INC. 8-K

What Happened

• Splash Beverage Group, Inc. filed an 8-K reporting a strategic pivot into the cannabinoid health and pharma space. On June 9, 2026 the company invested $217,479.24 to buy 2,000,000 common shares and 1,000,000 warrants of Avicanna Inc. (TSX: AVCN).
• On June 8, 2026 the Board appointed Michael Bondurant as Chief Operating Officer and approved employment terms for Interim CEO Brady Cobb and Mr. Bondurant, including base salaries and performance bonus schedules. The Board also approved multiple 10‑year option grants and adopted (subject to stockholder approval) a Strategic Transformation Restricted Stock Unit (RSU) Plan.

Key Details

• Investment: $217,479.24 for 2,000,000 Avicanna common shares and 1,000,000 warrants (private placement) — transaction dated June 9, 2026.
• COO appointment: Michael Bondurant named COO effective June 8, 2026; background includes senior roles in cannabis operations and M&A experience.
• Executive pay & bonuses: Brady Cobb — $300,000 base salary; Michael Bondurant — $275,000 base. Both eligible for performance bonuses tied to market capitalization thresholds (e.g., $50k at +$5M market cap; additional bonuses if >$10M, plus 3% of further increases up to $300k).
• Option grants: 10‑year options at $0.25 exercise price granted June 8, 2026 totaling all shares reserved under the 2025 Equity Incentive Plan (notable grants: Cobb 925,000; Bondurant 800,000; CFO Martin Scott 700,000; several directors/consultants also granted options).
• RSU Plan: Board adopted a Strategic Transformation RSU Plan representing 20% of fully diluted shares (~8,373,000 shares presently); plan is subject to stockholder approval and ties vesting to closing a strategic transaction, NYSE compliance, and post‑closing milestones.

Why It Matters

• These actions signal a strategic shift toward the cannabinoid wellness/pharma sector: the Avicanna investment and management hires align with that pivot.
• Executive compensation and option grants align leadership incentives with market‑cap gains and a successful transformational transaction, but also introduce potential future dilution (RSU Plan proposed at 20% of fully diluted shares and multiple option grants).
• Stockholder approval is required for the RSU Plan, and the plan is expected to be an express closing condition for any major transaction — investors should watch upcoming proxy votes, any further transaction announcements, and how these moves affect share count and corporate strategy execution.